PTP4A3 and non-small cell lung carcinoma: The combination of PTP4A3 with immune cells is proposed as a predictor for immunotherapy response and prognosis in renal cancers, with potential applications in other cancer types such as NSCLC or gastric cancer as well (57, 58).